Dennis M, Burnett A, Hills R, Thomas I, et al. A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial. Br J Haematol 2021;194:298-308.
PMID: 33961292